PubMed:19891556 / 759-959
Annnotations
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 6782 | 46-57 | ChemicalEntity | denotes | clopidogrel | MESH:D000077144 |
| 6783 | 111-118 | GeneOrGeneProduct | denotes | CYP2C19 | NCBIGene:1557 |
| 6784 | 131-142 | ChemicalEntity | denotes | clopidogrel | MESH:D000077144 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 0-200 | Sentence | denotes | Consequently, the US FDA has recently changed clopidogrel's prescribing information to highlight the impact of CYP2C19 genotype on clopidogrel pharmacokinetics, pharmacodynamics and clinical response. |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 101-107 | GeneOrGeneProduct | denotes | impact |
| T10 | 111-118 | GeneOrGeneProduct | denotes | CYP2C19 |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 101-107 | GeneOrGeneProduct | denotes | impact |
| T4 | 111-118 | GeneOrGeneProduct | denotes | CYP2C19 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 111-118 | GeneOrGeneProduct | denotes | CYP2C19 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T13 | 131-142 | ChemicalEntity | denotes | clopidogrel | D000077144|http://purl.obolibrary.org/obo/CHEBI_37941|ChemicalEntity |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T13 | 131-142 | ChemicalEntity | denotes | clopidogrel | ChemicalEntity|http://purl.obolibrary.org/obo/CHEBI_37941|D000077144 |
| T3 | 111-118 | GeneOrGeneProduct | denotes | CYP2C19 |